lb pharmaceuticals
PrivateLast Round
IPO Announced
Sep 10, 2025
Last Round Size
$285M
Est. Valuation
$872.75M
Total Funding Raised
$506.93M
Company Overview
LB Pharmaceuticals is a biotechnology company focused on developing innovative treatments for schizophrenia, utilizing a pro-drug approach to enhance the efficacy and safety of amisulpride for improved patient outcomes.
Sector
Biotech
Historical Pricing
Historical view of private secondary pricing and transaction trends.
lb pharmaceuticals Comps
Related companies by embedding similarity.
lb pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO Announced | Sep 10, 2025 | ||||
| Series C | Jan 24, 2024 | ||||
| Series C | Aug 29, 2023 | ||||
| Series B | Sep 25, 2020 | ||||
| Series B | Aug 18, 2020 | ||||
Series A | Mar 4, 2019 |
lb pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about lb pharmaceuticals's valuation, stock price, and market status.
